QT Interval Early Negative Signal Would Lessen Burden In Later Trials
Executive Summary
QT interval prolongation may not need to be evaluated "intensively" in late phase trials if preclinical and Phase I studies do not show a positive signal, participants in a Drug Information Association workshop generally agreed